RhumbLine Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-4,536
| Closed | -$79K | – | 3014 |
|
2019
Q1 | $79K | Buy |
4,536
+49
| +1% | +$853 | ﹤0.01% | 2888 |
|
2018
Q4 | $61K | Buy |
4,487
+1,314
| +41% | +$17.9K | ﹤0.01% | 2928 |
|
2018
Q3 | $68K | Sell |
3,173
-8
| -0.3% | -$171 | ﹤0.01% | 2895 |
|
2018
Q2 | $136K | Buy |
3,181
+305
| +11% | +$13K | ﹤0.01% | 2835 |
|
2018
Q1 | $188K | Buy |
2,876
+410
| +17% | +$26.8K | ﹤0.01% | 2621 |
|
2017
Q4 | $180K | Sell |
2,466
-348
| -12% | -$25.4K | ﹤0.01% | 2662 |
|
2017
Q3 | $258K | Buy |
2,814
+42
| +2% | +$3.85K | ﹤0.01% | 2617 |
|
2017
Q2 | $183K | Sell |
2,772
-36
| -1% | -$2.38K | ﹤0.01% | 2789 |
|
2017
Q1 | $609K | Buy |
2,808
+91
| +3% | +$19.7K | ﹤0.01% | 2166 |
|
2016
Q4 | $251K | Buy |
2,717
+79
| +3% | +$7.3K | ﹤0.01% | 2575 |
|
2016
Q3 | $357K | Sell |
2,638
-739
| -22% | -$100K | ﹤0.01% | 2390 |
|
2016
Q2 | $342K | Buy |
3,377
+887
| +36% | +$89.8K | ﹤0.01% | 2450 |
|
2016
Q1 | $408K | Buy |
2,490
+9
| +0.4% | +$1.48K | ﹤0.01% | 2355 |
|
2015
Q4 | $813K | Buy |
2,481
+81
| +3% | +$26.5K | ﹤0.01% | 1940 |
|
2015
Q3 | $774K | Sell |
2,400
-80
| -3% | -$25.8K | ﹤0.01% | 1939 |
|
2015
Q2 | $988K | Buy |
2,480
+45
| +2% | +$17.9K | ﹤0.01% | 1879 |
|
2015
Q1 | $1.2M | Buy |
2,435
+409
| +20% | +$201K | ﹤0.01% | 1744 |
|
2014
Q4 | $725K | Buy |
2,026
+191
| +10% | +$68.3K | ﹤0.01% | 2017 |
|
2014
Q3 | $354K | Sell |
1,835
-22
| -1% | -$4.24K | ﹤0.01% | 2431 |
|
2014
Q2 | $444K | Buy |
1,857
+171
| +10% | +$40.9K | ﹤0.01% | 2351 |
|
2014
Q1 | $431K | Sell |
1,686
-46
| -3% | -$11.8K | ﹤0.01% | 2316 |
|
2013
Q4 | $343K | Hold |
1,732
| – | – | ﹤0.01% | 2506 |
|
2013
Q3 | $293K | Buy |
1,732
+4
| +0.2% | +$677 | ﹤0.01% | 2541 |
|
2013
Q2 | $307K | Buy |
+1,728
| New | +$307K | ﹤0.01% | 2621 |
|